Results of Operations and Financial Condition On July 31, 2026, Balchem Corporation reported earnings for the quarter ended June 30, 2026, and certain other information. The full text of the press release issued in connection with the announcement is attached as Exhibit 99.1. The information in this Form 8-K (including Exhibit 99.1) shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”) or otherwise subject to the liabilities of that…

Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant. The information contained in

Entry into a Material Definitive Agreement. On July 24, 2026, Balchem Corporation, a Maryland corporation (“ Balchem ”), together with its foreign subsidiary Balchem B.V. (the “ Foreign Borrower ”), and certain domestic subsidiaries acting as guarantors (the “ Domestic Guarantors ”), entered into Amendment No. 1 (the “ Credit Agreement Amendment ”) to that certain Amended and Restated Credit Agreement, dated as of July 27, 2022 (the “ Credit Agreement ”) with JPMorgan Chase Bank, N.A. and JPM…

Results of Operations and Financial Condition On April 30, 2026, Balchem Corporation reported earnings for the quarter ended March 31, 2026, and certain other information. The full text of the press release issued in connection with the announcement is attached as Exhibit 99.1. The information in this Form 8-K (including Exhibit 99.1) shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”) or otherwise subject to the liabilities of th…

Results of Operations and Financial Condition On February 20, 2026, Balchem Corporation, reported earnings for the quarter ended December 31, 2025, and certain other information. The full text of the press release issued in connection with the announcement is attached as Exhibit 99.1. The information in this Form 8-K (including Exhibit 99.1) shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”), as amended, or otherwise subject to t…

Vice President and Chief Accounting Officer — William A. Backus: William A. Backus is retiring and Erin L. Gilson has been elected as the new Vice President and Chief Accounting Officer.

Regulation FD Disclosure. On December 10, 2025, Balchem Corporation (the “Company”) issued a press release announcing a dividend declared by the Company's Board of Directors on December 9, 2025. A copy of the press release is attached as Exhibit 99.1 to this Current Report on Form 8-K. Further, on December 9, 2025, the Board of Directors of the Company approved a new stock repurchase program which replaces the previous program that was in place and authorizes the repurchase of up to, and incl…

Results of Operations and Financial Condition On October 21, 2025, Balchem Corporation reported earnings for the quarter ended September 30, 2025, and certain other information. The full text of the press release issued in connection with the announcement is attached as Exhibit 99.1. The information in this Form 8-K (including Exhibit 99.1) shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”) or otherwise subject to the liabilities…

Results of Operations and Financial Condition On July 31, 2025, Balchem Corporation, reported earnings for the quarter ended June 30, 2025, and certain other information. The full text of the press release issued in connection with the announcement is attached as Exhibit 99.1. The information in this Form 8-K (including Exhibit 99.1) shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”) or otherwise subject to the liabilities of tha…

Results of Operations and Financial Condition On April 24, 2025, Balchem Corporation, reported earnings for the quarter ended March 31, 2025, and certain other information. The full text of the press release issued in connection with the announcement is attached as Exhibit 99.1. The information in this Form 8-K (including Exhibit 99.1) shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”) or otherwise subject to the liabilities of t…

Chief Accounting Officer — William A. Backus: The filing discloses a planned retirement of the Chief Accounting Officer with a notice period of over a year, indicating an orderly succession rather than a sudden loss.

Results of Operations and Financial Condition On February 21, 2025, Balchem Corporation, reported earnings for the quarter ended December 31, 2024, and certain other information. The full text of the press release issued in connection with the announcement is attached as Exhibit 99.1. The information in this Form 8-K (including Exhibit 99.1) shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”), as amended, or otherwise subject to t…

The filing discloses the adoption of a new executive severance policy and a deferred compensation match, which are compensatory arrangements rather than a change in personnel.

Regulation FD Disclosure. On December 10, 2024, Balchem Corporation (the “Company”) issued a press release announcing a dividend declared by the Company's Board of Directors on December 9, 2024. A copy of the press release is attached as Exhibit 99.1 to this Current Report on Form 8-K.

Results of Operations and Financial Condition On October 25, 2024 , Balchem Corporation, reported earnings for the quarter ended September 30, 2024, and certain other information. The full text of the press release issued in connection with the announcement is attached as Exhibit 99.1. The information in this Form 8-K (including Exhibit 99.1) shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”) or otherwise subject to the liabiliti…

Director — Joyce Lee: A director resigned due to a planned change in employment, which is a standard board turnover event rather than a senior executive departure.

Director: The filing describes a routine administrative reclassification of existing directors to rebalance board classes, with no actual departure from the board.

Results of Operations and Financial Condition On July 26, 2024, Balchem Corporation, reported earnings for the quarter ended June 30, 2024, and certain other information. The full text of the press release issued in connection with the announcement is attached as Exhibit 99.1. The information in this Form 8-K (including Exhibit 99.1) shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”) or otherwise subject to the liabilities of tha…

Results of Operations and Financial Condition On May 3, 2024, Balchem Corporation, reported earnings for the quarter ended March 31, 2024, and certain other information. The full text of the press release issued in connection with the announcement is attached as Exhibit 99.1. The information in this Form 8-K (including Exhibit 99.1) shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”) or otherwise subject to the liabilities of that…

Senior Vice President — Jonathan H. Griffin: The filing discloses an internal lateral move/promotion of a Senior Vice President to a new Corporate Development role, which is not a departure.